The legacy of Viagra and the pharmaceutical industry presents a intricate picture for potential investors. Initially, copyright's remarkable drug altered the treatment of erectile dysfunction, generating massive profits and defining the current pharmaceutical landscape. However, patent expiration and the rise of off-brand versions have sharply erod